Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Salvacyl 11.25mg powder and solvent for prolonged-release suspension for injection vials (Ipsen Ltd) |
| BNF code | 0803042W0BCAAAA |
| Virtual Medicinal Product | Triptorelin 11.25mg powder and solvent for prolonged-release suspension for injection vials |
| Name | Salvacyl 11.25mg powder and solvent for prolonged-release suspension for injection vials |
| Abbreviated name | Salvacyl 11.25mg inj vials |
| Date of name applicability | 1 Jan 2025 |
| Previous name | Salvacyl 11.25mg powder and solvent for suspension for injection vials |
| Supplier | Ipsen Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Salvacyl 11.25mg powder and solvent for prolonged-release suspension for injection vials (Ipsen Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.